To the Editor: In their randomized controlled
trial, Dr Nissen and colleagues1 reported
that a daily dose of 80 mg of atorvastatin was associated with a greater reduction
in the volume of coronary atheromas than was a daily dose of 40 mg of pravastatin.
The authors concluded that their results supported aggressive cholesterol-lowering
Ravnskov U, Sutter MC. Aggressive Lipid-Lowering Therapy and Regression of Coronary Atheroma. JAMA. 2004;292(1):38. doi:10.1001/jama.292.1.38-a